Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Mostoles – page 4

65 clinical trials in Mostoles, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Mostoles at a glance
65
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

65 trials in Mostoles

Open in trial search

COVID-19

Not recruiting

Safety and Immunogenicity of SARS-COV-2 VIRUS, VARIANT LP.8.1, SPIKE PROTEIN, RECEPTOR BINDING DOMAIN FUSION HOMODIMER Vaccine in Adults with COVID-19

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:SARS-COV-2 VIRUS, VARIANT LP.8.1, SPIKE PROTEIN, RECEPTOR BINDING DOMAIN FUSION HOMODIMER
  • Sponsor:Hipra Scientific S.L.

Phase III Study Comparing FOLFOX Plus Panitumumab Followed by FOLFIRI Plus Bevacizumab Versus FOLFOX Plus Bevacizumab Followed by FOLFIRI Plus Panitumumab in Wild-Type RAS Metastatic Colorectal Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Asociacion Grupo Tratamiento De Tumores Digestivos

Efficacy, Safety, and Immunogenicity of mRNA-1647 Vaccine in Preventing Primary Cytomegalovirus Infection in CMV-Seronegative Females Aged 16-40

Registered drug
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Substances:Sodium Chloride
  • Sponsor:Moderna Inc.

A study comparing cagrilintide and semaglutide combination to semaglutide, cagrilintide, and placebo in adults with type 2 diabetes on metformin

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

COVID-19

Not recruiting

A study to test the safety and immune response of PHH-1V111 vaccine against COVID-19 variants in adults

Registered drugNo placebo
Countries:SpainSpain
  • Participants:65+ years · Healthy volunteers
  • Substances:PHH-1V111
  • Sponsor:Hipra Scientific S.L.

Migraine

Not recruiting

Study of rimegepant for preventing chronic migraine in adolescents aged 12 to 17 years

Registered drug
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Rimegepant sulfate
  • Sponsor:Pfizer Inc.

Study on the Effectiveness and Safety of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Toddlers

Investigational
Countries:SpainSpain
  • Participants:0–17 years · Healthy volunteers
  • Substances:534
  • Sponsor:Sanofi Pasteur Inc.

COVID-19

Not recruiting

Study on the Safety and Immune Response of PHH-1V81 Booster for Adults Vaccinated Against COVID-19

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Raxtozinameran
  • Sponsor:Hipra Scientific S.L.

Study on the Safety and Immune Response of mRNA-1345 and mRNA-1365 for Infants with Acute Lower Respiratory Infection Aged 5 to 24 Months

Registered drug
Countries:SpainSpain
  • Participants:0–17 years · Healthy volunteers
  • Substances:MRNA-1345
  • Sponsor:Moderna Inc.

Safety and immunogenicity study of Pentavalent Meningococcal ABCYW vaccine (MenPenta SD and MenPenta fHD) compared to licensed meningococcal vaccines in infants, toddlers and children

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years · Healthy volunteers
  • Substances:Diphtheria toxoid
  • Sponsor:Sanofi Pasteur Inc.

COVID-19

Not recruiting

Study on the Safety and Immune Response of BIMERVAX as a COVID-19 Booster in Adolescents Aged 12 to 17 Years

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years · Healthy volunteers
  • Substances:SARS-COV-2 VIRUS, VARIANTS B.1.351-B.1.1.7, SPIKE PROTEIN, RECEPTOR BINDING DOMAIN FUSION HETERODIMER
  • Sponsor:Hipra Scientific S.L.
Countries:SpainSpain
  • Participants:18–64 years · Healthy volunteers
  • Substances:GSKVX000000044501
  • Sponsor:GlaxoSmithKline Biologicals

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Mostoles

What the registry says about research in the country

01 Infectious Disease Prevention

Comprehensive vaccine research focusing on preventive immunization against multiple viral infections. Studies include trials for MMRV vaccines, UTI prevention, and CMV protection in various age groups.

  • Combined childhood vaccines
  • Urinary tract infection prevention
  • Cytomegalovirus immunity

Trials evaluate immune responses, safety profiles, and vaccine efficacy across different populations.

02 Respiratory Health

Advanced research into respiratory infections and treatments, with particular focus on RSV prevention and COVID-19 variants. Studies target both pediatric and adult populations.

  • RSV vaccine development
  • COVID-19 booster efficacy
  • Lower respiratory tract infections

Emphasis on developing next-generation vaccines and testing novel therapeutic approaches.

03 Oncology Research

Innovative trials in cancer treatment, particularly focusing on breast cancer and multiple myeloma. Studies evaluate new therapeutic combinations and treatment strategies.

  • HER2-positive breast cancer therapy
  • Multiple myeloma treatments
  • Metastatic colorectal cancer management

Research aims to improve treatment outcomes and patient survival rates.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.